-mig
A bispecific or multispecific antibody: one molecule built to bind two or more different targets. Part of the 2021 scheme.
- Drugs ending in -mig: 63
- Approved somewhere: 0
- With a US drug page: 0
- Stem
- -mig
- Class
- Bispecific and multispecific antibodies (2021 naming scheme)
Approved and clinical-stage drugs in ChEMBL whose names ending in -mig, matched by spelling; those with a US drug page link to it.
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO